{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:47:18Z","timestamp":1791316038664,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jpba.2022.115119","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T12:20:07Z","timestamp":1666354807000},"page":"115119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["LC and LC-MS\/MS studies for identification and characterization of degradation products of d-tubocurarine chloride"],"prefix":"10.1016","volume":"223","author":[{"given":"Parul","family":"Grover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srashti","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7335-7014","authenticated-orcid":false,"given":"Lovekesh","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2022.115119_bib1","series-title":"The Editors of Encyclopaedia. \"curare\"","author":"Britannica","year":"2016"},{"key":"10.1016\/j.jpba.2022.115119_bib2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.97.2525.467","article-title":"Curare alkaloids from Chondodendron tomentosum","volume":"97","author":"Wintersteiner","year":"1943","journal-title":"Science"},{"key":"10.1016\/j.jpba.2022.115119_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/014107680209500713","article-title":"Neuromuscular blocking drugs: discovery and development","volume":"95","author":"Raghavendra","year":"2002","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.jpba.2022.115119_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0310057X7200100111","article-title":"Clinical comparison of tubocurarine and pancuronium","volume":"1","author":"Joseph","year":"1972","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.jpba.2022.115119_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0773.1994.tb01065.x","article-title":"Newer neuromuscular blocking agents","volume":"74","author":"Bevan","year":"1994","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.jpba.2022.115119_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1098\/rspb.1991.0065","article-title":"Direct measurement of the action of acetylcholine on isolated outer hair cells of the guinea pig cochlea","volume":"244","author":"Housley","year":"1991","journal-title":"Proc. R. Soc. Lond. B"},{"key":"10.1016\/j.jpba.2022.115119_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0378-5955(94)90182-1","article-title":"In vitro pharmacologic characterization of a cholinergic receptor on outer hair cells","volume":"74","author":"Erostegui","year":"1994","journal-title":"Hear. Res."},{"key":"10.1016\/j.jpba.2022.115119_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fncel.2017.00262","article-title":"d-Tubocurarine and berbamine: alkaloids that are permeant blockers of the hair cell\u2019s mechano-electrical transducer channel and protect from aminoglycoside toxicity","volume":"11","author":"Kirkwood","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jpba.2022.115119_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110061","article-title":"Supplemental treatment to atropine improves the efficacy to reverse nerve agent induced bronchoconstriction","volume":"364","author":"Wigenstam","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jpba.2022.115119_bib10","article-title":"Repositioning of tubocurarine as analgesic and anti-inflammatory agent: exploring beyond myorelaxant activity","volume":"14","author":"Patel","year":"2022","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.jpba.2022.115119_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.22146\/ijc.56745","article-title":"Adsorption and inhibition analysis of aconitine and tubocurarine alkaloids as eco-friendly inhibitors of pitting corrosion in ASTM\u2013A47 low carbon steel in HCl acid environment","volume":"22","author":"Ugi","year":"2022","journal-title":"Indones. J. Chem."},{"key":"10.1016\/j.jpba.2022.115119_bib12","doi-asserted-by":"crossref","first-page":"23195","DOI":"10.1074\/jbc.272.37.23195","article-title":"Determinants of apamin and d-tubocurarine block in SK potassium channels","volume":"272","author":"Ishii","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2022.115119_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00000542-198209000-00009","article-title":"Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults","volume":"57","author":"Fisher","year":"1982","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpba.2022.115119_bib14","unstructured":"ICH, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Harmonised Tripartite Guideline: Impurities in new drug substances Q3A(R2), Geneva, 2006."},{"key":"10.1016\/j.jpba.2022.115119_bib15","unstructured":"ICH, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Harmonised Tripartite Guideline: Impurities in New Drug Products Q3B(R2), Geneva, 2006."},{"key":"10.1016\/j.jpba.2022.115119_bib16","unstructured":"ICH, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Harmonised Tripartite Guideline: Stability Testing of New Drug Substances and Products Q1A(R2), Geneva, 2003, pp. 1\u201324."},{"key":"10.1016\/j.jpba.2022.115119_bib17","unstructured":"ICH, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Harmonised Tripartite Guideline: Photostability testing of new drug substances and products Q1B(R2), Geneva, 2003, pp. 1\u201324."},{"key":"10.1016\/j.jpba.2022.115119_bib18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0021-9673(01)92079-5","article-title":"Quantitative analysis of d-tubocurarine chloride in curare by column liquid chromatography","volume":"142","author":"Van der Maeden","year":"1977","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2022.115119_bib19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0378-4347(00)80906-8","article-title":"Determination of d-tubocurarine chloride or metocurine iodide in human plasma by high-performance liquid chromatography with ultraviolet detection","volume":"306","author":"Avram","year":"1984","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.jpba.2022.115119_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0378-4347(00)84231-0","article-title":"Quantitation of d-tubocurarine in human plasma using high-performance liquid chromatography","volume":"226","author":"Meulemans","year":"1981","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.jpba.2022.115119_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0378-4347(00)82503-7","article-title":"Measurement of D-tubocurarine chloride in human urine using solid-phase extraction and reversed-phase high-performance liquid chromatography with ultraviolet detection","volume":"526","author":"Annan","year":"1990","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.jpba.2022.115119_bib22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0378-4347(00)82209-4","article-title":"Simple high-performance liquid chromatographic method for the analysis of the non-depolarizing neuromuscular blocking drugs in clinical anaesthesia","volume":"533","author":"Bjorksten","year":"1990","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.jpba.2022.115119_bib23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.36468\/pharmaceutical-sciences.727","article-title":"Development and validation of novel and highly sensitive stability-indicating reverse phase ultra performance liquid chromatography method for quantification of ibrutinib and its ten degradation products","volume":"82","author":"Mehta","year":"2020","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2022.115119_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113768","article-title":"LC and LC\u2013MS\/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway","volume":"194","author":"Mehta","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.115119_bib25","first-page":"1","article-title":"Identification and characterization of new degradation products of belinostat using UHPLC-Q-TOF-MS\/MS and in silico toxicity prediction","author":"Mehta","year":"2021","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2022.115119_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114351","article-title":"LC-MS\/MS studies for identification and characterization of new forced degradation products of dabrafenib and establishment of their degradation pathway","volume":"206","author":"Grover","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.115119_bib27","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.5530\/ijper.56.1s.43","article-title":"Identification and characterization of in vitro metabolites of belinostat by rat liver microsomes using ultra performance liquid chromatography coupled with tandem mass spectrometry","volume":"56","author":"Grover","year":"2022","journal-title":"Indian J. Pharm. Educ. Res."},{"key":"10.1016\/j.jpba.2022.115119_bib28","first-page":"762","article-title":"Identification and characterization of in vitro metabolites of ibrutinib by rat liver microsomes using ultra performance liquid chromatography coupled with tandem mass spectrometry","volume":"84","author":"Grover","year":"2022","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2022.115119_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/2229-5186.79345","article-title":"Methods for the determination of limit of detection and limit of quantitation of the analytical methods","volume":"2","author":"Shrivastava","year":"2011","journal-title":"Chron. Young Sci."},{"key":"10.1016\/j.jpba.2022.115119_bib30","first-page":"82","article-title":"Separation of four impurities and degradants by LC: a case of bicalutamide","volume":"41","author":"Mittal","year":"2021","journal-title":"Hacet. Univ. J. Fac. Pharm."},{"key":"10.1016\/j.jpba.2022.115119_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115045","article-title":"Identification and Characterization of Forced degradation products of Sertraline Hydrochloride Using UPLC, Ultra-High-Performance Liquid Chromatography-Quadrupole-Time of Flight Mass Spectrometry (UHPLC-Q-TOF\/MS\/MS) and NMR","volume":"221","author":"Grover","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.115119_bib32","unstructured":"ICH, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Harmonised Tripartite Guideline: Validation of Analytical Procedures: Text and Methodology Q2(R1), 2005, pp. 1\u201317."},{"key":"10.1016\/j.jpba.2022.115119_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jsps.2017.12.014","article-title":"Simultaneous determination of naltrexone and bupropion in their co-formulated tablet utilizing green chromatographic approach with application to human urine","volume":"26","author":"Abdel-Gawad","year":"2018","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.jpba.2022.115119_bib34","first-page":"688","article-title":"Gold nanoparticles conjugated with rituximab for the treatment of chronic lymphocytic leukaemia","volume":"64","author":"Boca","year":"2016","journal-title":"Farmacia"},{"key":"10.1016\/j.jpba.2022.115119_bib35","doi-asserted-by":"crossref","first-page":"888","DOI":"10.5530\/ijper.56.3.142","article-title":"Development and validation of novel and highly sensitive stability-indicating reverse phase UPLC method for quantification of dabrafenib and its ten degradation products","volume":"56","author":"Grover","year":"2022","journal-title":"Indian J. Pharm. Educ. Res."},{"key":"10.1016\/j.jpba.2022.115119_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.15415\/jptrm.2013.12012","article-title":"Analytical method development and validation for assay of rufinamide drug","volume":"1","author":"Singh","year":"2013","journal-title":"J. Pharm. Technol. Res. Manag."},{"key":"10.1016\/j.jpba.2022.115119_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03530","article-title":"Stability indicating liquid chromatography method for the analysis of Vecuronium bromide: study of the degradation profile","volume":"6","author":"Abd Elrahman","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.jpba.2022.115119_bib38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jat\/30.1.57","article-title":"Qualitative identification of doxacurium and its breakdown products in postmortem fluids by liquid chromatography-tandem mass spectrometry","volume":"30","author":"Montgomery","year":"2006","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2022.115119_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/chromsci\/bms252","article-title":"Analysis of rocuronium in human whole blood and tissues using liquid chromatography\u2013tandem mass spectrometry","volume":"51","author":"Cho","year":"2013","journal-title":"J. Chromatogr. Sci."},{"issue":"7","key":"10.1016\/j.jpba.2022.115119_bib40","article-title":"Determination of rocuronium in human plasma by high performance liquid chromatography-tandem mass spectrometry and its pharmacokinetics in patients","volume":"4","author":"Yuan G","year":"2012","journal-title":"J. Bioequiv. Availab."},{"key":"10.1016\/j.jpba.2022.115119_bib41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jpba.2013.11.032","article-title":"Analysis of rocuronium in human plasma by liquid chromatography\u2013tandem mass spectrometry with application in clinical pharmacokinetics","volume":"90","author":"de Moraes","year":"2014","journal-title":"J. Pharm. Biomed."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522005404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522005404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:24:03Z","timestamp":1760001843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708522005404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":41,"alternative-id":["S0731708522005404"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115119","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LC and LC-MS\/MS studies for identification and characterization of degradation products of d-tubocurarine chloride","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115119"}}